We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.8M
Cap. Flow %
4.57%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
790
Reduced
1,480
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWD icon
1326
iShares MSCI Sweden ETF
EWD
$594M
$19K ﹤0.01%
599
-3,570
-86% -$109K
EXP icon
1327
Eagle Materials
EXP
$6.61B
$19K ﹤0.01%
+200
New +$20.4K
GMED icon
1328
Globus Medical
GMED
$11B
$19K ﹤0.01%
652
-3,252
-83% -$88.8K
GRP.U
1329
DELISTED
Granite Real Estate Investment Trust
GRP.U
$19K ﹤0.01%
400
-1,600
-80% -$54.5K
IRIX icon
1330
IRIDEX
IRIX
$14.8M
$19K ﹤0.01%
1,579
+715
+83% +$10K
IWF icon
1331
iShares Russell 1000 Growth ETF
IWF
$128B
$19K ﹤0.01%
+684
New +$19K
KEP icon
1332
Korea Electric Power
KEP
$16B
$19K ﹤0.01%
932
-1,054
-53% -$19.8K
KFRC icon
1333
Kforce
KFRC
$1.03B
$19K ﹤0.01%
+800
New +$19.1K
LRMR icon
1334
Larimar Therapeutics
LRMR
$429M
$19K ﹤0.01%
335
+81
+32% +$4.02K
MLKN icon
1335
MillerKnoll
MLKN
$1.67B
$19K ﹤0.01%
588
+80
+16% +$2.48K
MMM icon
1336
3M
MMM
$92.9B
$19K ﹤0.01%
120
-27,738
-100% -$4.25M
NTNX icon
1337
Nutanix
NTNX
$16.6B
$19K ﹤0.01%
989
+489
+98% +$13.1K
NVEE
1338
DELISTED
NV5 Global
NVEE
$19K ﹤0.01%
2,000
-1,284
-39% -$12.1K
ADAM
1339
Adamas Trust
ADAM
$859M
$19K ﹤0.01%
750
+481
+179% +$12.4K
PVH icon
1340
PVH
PVH
$4.07B
$19K ﹤0.01%
180
-1,416
-89% -$131K
QCRH icon
1341
QCR Holdings
QCRH
$1.73B
$19K ﹤0.01%
459
+329
+253% +$14.1K
VSTM icon
1342
Verastem
VSTM
$508M
$19K ﹤0.01%
774
-1,875
-71% -$29.8K
DVD
1343
DELISTED
Dover Motorsports
DVD
$19K ﹤0.01%
8,502
+815
+11% +$1.84K
JE
1344
DELISTED
Just Energy Group Inc
JE
$19K ﹤0.01%
91
+26
+40% +$5K
CARB
1345
DELISTED
Carbonite Inc
CARB
$19K ﹤0.01%
932
-384
-29% -$7.21K
APU
1346
DELISTED
AmeriGas Partners, L.P.
APU
$19K ﹤0.01%
+400
New +$18.9K
DM
1347
DELISTED
Dominion Energy Midstream Ptr LP
DM
$19K ﹤0.01%
+600
New +$18.8K
FINL
1348
DELISTED
Finish Line
FINL
$19K ﹤0.01%
1,352
-1,380
-51% -$23.2K
OAKS
1349
DELISTED
Five Oaks Investment Corp.
OAKS
$19K ﹤0.01%
3,653
-5,166
-59% -$26.6K
CALD
1350
DELISTED
Callidus Software, Inc.
CALD
$19K ﹤0.01%
900
-2,999
-77% -$57.6K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.8M of net new capital in Q1 2017, opening 814 new positions and adding to 790 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.